End-of-day quote
Taipei Exchange
03:30:00 17/05/2024 am IST
|
5-day change
|
1st Jan Change
|
42.7
TWD
|
+5.17%
|
|
+18.94%
|
+45.98%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
1,850
|
2,338
|
2,121
|
2,326
|
2,352
|
2,752
|
Enterprise Value (EV)
1 |
2,187
|
2,625
|
2,473
|
2,693
|
2,601
|
2,911
|
P/E ratio
|
8.87
x
|
11.3
x
|
14.9
x
|
15.6
x
|
8.68
x
|
13.4
x
|
Yield
|
8.31%
|
6.64%
|
6.14%
|
5.8%
|
8%
|
5.98%
|
Capitalization / Revenue
|
0.74
x
|
0.93
x
|
0.9
x
|
0.82
x
|
0.84
x
|
1.12
x
|
EV / Revenue
|
0.88
x
|
1.05
x
|
1.04
x
|
0.95
x
|
0.93
x
|
1.18
x
|
EV / EBITDA
|
6.21
x
|
6.7
x
|
5.9
x
|
5.26
x
|
6.15
x
|
8.13
x
|
EV / FCF
|
-9.78
x
|
11.7
x
|
12.8
x
|
26.3
x
|
14.3
x
|
11.7
x
|
FCF Yield
|
-10.2%
|
8.57%
|
7.79%
|
3.8%
|
6.99%
|
8.54%
|
Price to Book
|
1.03
x
|
1.3
x
|
1.21
x
|
1.32
x
|
1.21
x
|
1.4
x
|
Nbr of stocks (in thousands)
|
96,090
|
94,091
|
93,033
|
93,033
|
94,091
|
94,091
|
Reference price
2 |
19.25
|
24.85
|
22.80
|
25.00
|
25.00
|
29.25
|
Announcement Date
|
11/03/19
|
18/03/20
|
31/03/21
|
07/03/22
|
13/03/23
|
29/02/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
2,488
|
2,502
|
2,368
|
2,848
|
2,808
|
2,459
|
EBITDA
1 |
351.9
|
391.7
|
418.8
|
512.2
|
423.2
|
357.9
|
EBIT
1 |
227.5
|
272.1
|
290.7
|
379.6
|
290.4
|
228.5
|
Operating Margin
|
9.15%
|
10.88%
|
12.28%
|
13.33%
|
10.34%
|
9.29%
|
Earnings before Tax (EBT)
1 |
253.4
|
256
|
191.3
|
193.3
|
352.7
|
235.9
|
Net income
1 |
209.3
|
208.4
|
144.1
|
150.6
|
274.3
|
208.3
|
Net margin
|
8.41%
|
8.33%
|
6.08%
|
5.29%
|
9.77%
|
8.47%
|
EPS
2 |
2.170
|
2.200
|
1.530
|
1.600
|
2.880
|
2.190
|
Free Cash Flow
1 |
-223.5
|
225.1
|
192.6
|
102.4
|
181.7
|
248.5
|
FCF margin
|
-8.98%
|
8.99%
|
8.13%
|
3.6%
|
6.47%
|
10.11%
|
FCF Conversion (EBITDA)
|
-
|
57.45%
|
46%
|
20%
|
42.93%
|
69.43%
|
FCF Conversion (Net income)
|
-
|
108%
|
133.71%
|
68.01%
|
66.24%
|
119.31%
|
Dividend per Share
2 |
1.600
|
1.650
|
1.400
|
1.450
|
2.000
|
1.750
|
Announcement Date
|
11/03/19
|
18/03/20
|
31/03/21
|
07/03/22
|
13/03/23
|
29/02/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
337
|
287
|
352
|
367
|
249
|
159
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
0.9572
x
|
0.7333
x
|
0.84
x
|
0.7171
x
|
0.5874
x
|
0.444
x
|
Free Cash Flow
1 |
-223
|
225
|
193
|
102
|
182
|
249
|
ROE (net income / shareholders' equity)
|
12.5%
|
11.7%
|
8.11%
|
8.52%
|
14.6%
|
10.6%
|
ROA (Net income/ Total Assets)
|
4.86%
|
5.7%
|
5.86%
|
7.08%
|
5.48%
|
4.59%
|
Assets
1 |
4,311
|
3,659
|
2,458
|
2,126
|
5,007
|
4,535
|
Book Value Per Share
2 |
18.60
|
19.10
|
18.80
|
19.00
|
20.70
|
20.80
|
Cash Flow per Share
2 |
3.930
|
3.950
|
5.540
|
5.680
|
4.740
|
4.790
|
Capex
1 |
276
|
285
|
106
|
152
|
121
|
133
|
Capex / Sales
|
11.09%
|
11.38%
|
4.47%
|
5.35%
|
4.32%
|
5.39%
|
Announcement Date
|
11/03/19
|
18/03/20
|
31/03/21
|
07/03/22
|
13/03/23
|
29/02/24
|
|
1st Jan change
|
Capi.
|
---|
| +45.98% | 12Cr | | +5.41% | 11TCr | | -3.11% | 6.47TCr | | +73.33% | 4.97TCr | | +17.24% | 3.86TCr | | +6.13% | 3.25TCr | | +12.77% | 1.99TCr | | +15.03% | 1.69TCr | | +19.06% | 1.52TCr | | +6.28% | 1.44TCr |
Other Commodity Chemicals
|